Evidence browser
Explore the evidence
Loading the evidence…
Evidence browser
Loading the evidence…
Evidence browser
35,999 claims
Emergency department staff should be aware of the potential for NPS to induce psychiatric symptoms and understand which symptoms are associated with different types of NPS.
Studies included in this review recommend that emergency department staff should be aware of the potential of NPS to induce psychiatric symptoms and to understand which psychiatric symptoms might be more commonly associated with different groups of NPS.
Operational · Procedural statement · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 34
NPS can induce mental health conditions such as psychosis, agitation, insomnia, catatonia, anxiety, aggression, hallucinations, and suicidal ideation.
NPS use was cited in a number of studies as being a causal factor for inducing psychosis in addition to other mental health symptoms including; agitation, insomnia, catatonia, anxiety, aggression, hallucinations and suicidal ideation.
Service · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 34
The majority of studies included in the review focused on synthetic cannabinoids, with fewer papers considering other types of NPS.
Regarding the types of NPS considered within the included studies 5 papers considered multiple NPS types and did not limit the study to a specific substance or group of substances, 12 papers considered synthetic cannabinoids
Research · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 31
Limited evidence is available on the impact of NPS use in secure mental health settings, and further research is recommended.
This evidence review has highlighted that limited evidence available in this field and further research would be recommended to better address the research question
Research · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 30
The proportion of individuals accessing treatment for NPS use in secure settings is higher than in the community.
In secure settings the proportion of those accessing services for treatment for NPS use was higher than in the community with 6% of adults and 8% of young people in treatment reporting NPS as a problem substance
Research · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 29
The prevalence of NPS use among young people accessing substance misuse treatment services in England increased by 77% from the previous year.
In 2015/16 2,042 individuals presented to substance misuse treatment services for NPS in England, whilst this was a 77% increase on the previous year it still only represented 1.5% of all presentations
Research · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 29
NPS can induce psychiatric symptoms in individuals with no prior mental health diagnosis.
The results from the review indicate that NPS can induce psychiatric symptoms in those with no prior mental health diagnosis and can exacerbate symptoms in those with existing serious mental illness.
Research · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 30
Only around a fifth of units reported having a protocol in place for the treatment of people using NPS.
Regarding the management of NPS use only around a fifth of units reported having a protocol in place for the treatment of people using NPS, however over two fifths reporting having NPS treatment plans in place.
Service · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 20
Synthetic cannabinoids are the most commonly used type of NPS in secure mental health settings.
Higher reported use of synthetic cannabinoids was reported across all types of secure mental health setting. It is important to note that prevalence of NPS use of alongside other illicit substances was high across all types of secure mental health setting, with two thirds of NPS users reporting as using other illicit substances.
Service · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 23
Withdrawal symptoms from NPS use include physical and psychological effects such as nausea, vomiting, tremors, aggression, insomnia, and paranoia.
Physical symptoms that were associated with NPS withdrawal included: nausea, vomiting, sweating and tremors. Psychological symptoms that were associated with NPS withdrawal included: aggression, insomnia, irritability, anxiety, psychosis, paranoia and hallucinations.
Service · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 18
Acute clinical care was required for 52 incidents related to NPS use in the last year across 14 secure mental health units.
14 of the 66 secure mental health units reported the need for urgent clinical care related to NPS use in the last 12 months, this related to a total of 52 incidents.
Service · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 17
Psychosis is the most commonly reported psychological symptom associated with NPS use in secure mental health settings.
Psychosis was the most frequently reported psychological symptom to be associated with NPS use, followed by aggression, anger, paranoia, anxiety and hallucinations.
Service · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 17
Cardiovascular symptoms are the most frequently reported physical symptom associated with NPS use.
Cardiovascular symptoms were the most frequently reported physical symptom to be associated with NPS use, followed by reduced levels of consciousness, dizziness, vomiting and neuro-muscular symptoms.
Service · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 16
Synthetic cannabinoids are the most prevalent type of NPS used in secure mental health settings.
For all units synthetic cannabinoids were reported as the most prevalent NPS in use.
Service · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 15
The use of NPS may contribute to an increase in mental health prevalence and activity in secure settings.
o Have NPS induced psychiatric symptoms led to an increase in activity in secure mental health settings?
Research · Trend statement · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 10
There is a need for additional guidance and training on managing NPS use in secure mental health settings.
There is a need for additional guidance and training on the management of people using NPS specifically in secure mental health settings. This should build on the existing guidance developed for prisons by PHE, which has been subject to national evaluation.
Policy · Policy statement · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 10
NPS use is a significant issue affecting secure mental health units.
The feedback from the questionnaire has confirmed that NPS use is an issue that affects secure mental health units, both with regards to current use within the units and as a potential contributing factor for admission to the units.
Service · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 9
Clinicians should be aware of NPS-induced mental health symptoms and how to diagnose and treat them.
The findings from the review recommend that clinicians, specifically those in emergency department and acute mental health settings, are aware of the potential for NPS to induce mental health symptoms and how this can be diagnosed and treated.
Policy · Procedural statement · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 8
Further research is recommended to better understand the population-wide impact of NPS-induced mental illness, particularly long-term impacts.
However, due to the small number of studies available further research may need to be undertaken to determine the population wide impact of NPS induced mental illness, in particular the longer term impacts on mental health.
Research · Commitment statement · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 8
The review identified that NPS can induce psychiatric symptoms in those with no prior mental health diagnosis and exacerbate existing serious mental illness.
The results from the review indicate that NPS can induce psychiatric symptoms in those with no prior mental health diagnosis and can exacerbate symptoms in those with existing serious mental illness.
Service · Observational claim · From Psychoactive substances in secure mental health settings — A review of new psychoactive substances in secure mental health: summary document, page 8